$27.50 is about the 200 day average. When there is a full blown biotech correction it may go lower. I've cash ready to buy more in this case.
IMO this debacle is rather caused by internal politics than substantial insufficiencies of the current NDA filing process. It's a people issue not a science and procedural issue. That's a pity because it throws us back six months to reach the finish line.
Another sign this company is currently out of control. Probably Davis is producing this turmoil so in order to position himself better. I hope he is done soon and we can focus on real important things soon. I also hope he doesn't become the permanent ceo. He needs a strong leader.
That's certainly a valid point of view. However there is major damage done to investors trust and confidence.
I read the transcript of the February 26 cc and it sounded like Davis was already the " big " guy at that time. Currently I'm half way out, watching this very closely. I may reinvest in KERX after a correction which I still see coming.
Yes, you deserve the term village idiot. Congrats you brainless poster.
I don't think it's that easy you describe it. Management clearly has proven now its incompetence to file an nda. That's a big red flag for me. What's next? A news release like we are very disappointed but the data integrity seems to be not as great as we thought. Mills retires and Davis is the new interim CMO and chief developer plus ceo cfo and cbo. Rediculous. I'm half way out waiting for some good news in six months to justify the rest of my investment.
Before you realize BB and other institutions are dumping the pps will have tanked already. I'm not sure if this strategy will work.
Partnership would be cool of course at least for Europe but is there something lined up? They wanted it to do alone. I don't think it will happen right now with only an interim CEO at the helm.
The management is clearly incapable. However, if the data presented so far it is still a no brainer to get this through the FDA. Currently, I don't think the company has set up the biggest drug scam of all times but we have to watch progress now very very closely. It's a fine line management is walking on.
Pay the taxes on your gains and think about to reentry. How low has it to go to get the same number of shares after taxes. The result is you made a big mistake you will regret when everything pans out with the blockbuster. If you can't somatch such hiccups it is better for you to look for more robust stocks like GE. GL sorry to see you made this horrible decision.
I hope that doesn't happen too soon. I sold a lot of jan 2016 $40, $45, $50 calls. I'm in urgent need for cash to do the remodel and order the SL550 lol. Seriously, for a lucrative buyout we need PDP approval, adp data (positive) and around $ 300 mm in revenue. So next year will be the year where I think it can happen and won't have any short calls. If it happens this year I'm most likely f-ed with an average selling price of a bit over $50.
Congrats! Great move. I did a similar move last year with KERX. However, I sold everything to buy a home debt free. That's a great feeling.
Really? At least we have you as a professional on board. LOL
You are a very rude person you believes you know everything. But what you have posted I can tell you know nothing at all.
I think it is fair to extend this to 100 million patients equales $1trillion. That's when Acadia buys Pfizer et al and apple looks like pocket change. I luv it!!!